8.—(1) Where, in the course of providing NHS services, drugs are supplied to a patient in accordance with a Patient Group Direction, including during the out of hours period, the person supplying the drugs must, subject to paragraphs (3) to (5), make and recover from the patient for the supply of each quantity of a drug, a charge of £8.20.
(2) Any person paying a charge under paragraph (1) must on doing so sign a declaration in writing that the relevant charge has been paid.
(3) No charge is to be made and recovered under this regulation from a patient who is exempt—
(a)by virtue of section 173(1)(a) of the 2006 Act(1) (exemptions from general charging) or regulation 10(2), 11(1), 12 or 13;
(b)by virtue of regulation 10(1); or
(c)by reason of being entitled to remission of the charge by virtue of regulation 5 of the Travel Expenses and Remission of Charges Regulations(2) (entitlement to full remission and payment),
and who, in the cases described in sub-paragraphs (b) and (c), completes a declaration of entitlement to such exemption or remission and provides any other evidence of entitlement as the person supplying the drug may reasonably require.
(4) No charge is to be made and recovered under this regulation from a patient who is accepted by the person supplying the drug as—
(a)suffering from tuberculosis, in respect of any drug supplied to that patient for the treatment of tuberculosis; or
(b)being subject to a community treatment order, in respect of any drug supplied to that patient for the treatment of a mental disorder.
(5) No charge is to be made and recovered under this regulation where the drug is supplied for personal administration by the person making the supply in accordance with the Patient Group Direction.
(6) Where a patient requests a receipt for a charge made and recovered under paragraph (1), the person making that charge must give the patient a receipt for the amount received on the relevant approved form.
(7) For the purpose of this regulation, the reference to the supply of a drug in accordance with a Patient Group Direction is a reference to the supply of a drug for that purpose as provided for in the Human Medicines Regulations 2012(3).
Subsection (1) was amended by the Health Act 2009 (c. 21), Schedule 1, paragraphs 6 and 7(c).
Relevant amendments were made to regulation 5 by S.I. 2004/663 and 936, 2006/562, 2008/1697, 2009/411, 2013/475 and 2014/2667.
S.I. 2012/1916. See regulations 229 to 235 of those Regulations, which provide for the exemptions relating to Patient Group Directions from the general restrictions on the sale and supply of prescription only and pharmacy medicines.